Jentadueto (metformin linagliptin): Reviews and patient testimonials
Medication indications
Jentadueto 2.5 mg/850 mg and 2.5 mg/1,000 mg film-coated tablets
Jentadueto is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:
• in patients inadequately controlled on their maximally tolerated dose of metformin alone
• in combination with other medicinal products for the treatment of diabetes, including insulin, in patients inadequately controlled with metformin and these medicinal products
• in patients already being treated with the combination of linagliptin and metformin as separate tablets.
(see sections 4.4, 4.5 and 5.1 for available data on different combinations).
Route of administration: Oral
Molecule: metformin, linagliptin
Patients' opinions on Jentadueto
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.